Quintet Private Bank (Europe)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Sell
3,300
-300
-8% -$20K 0.01% 105
2026
Q1
$226K Buy
3,600
+100
+3% +$6.96K 0.02% 105
2025
Q4
$232K Hold
3,500
0.01% 105
2025
Q3
$236K Hold
3,500
0.01% 106
2025
Q2
$306K Hold
3,500
0.02% 97
2025
Q1
$239K Hold
3,500
0.01% 109
2024
Q4
$272K Sell
3,500
-605
-15% -$44.8K 0.02% 105
2024
Q3
$275K Buy
4,105
+3,137
+324% +$258K 0.02% 103
2024
Q2
$125K Buy
+968
New +$122K 0.01% 134

Other funds holding DXCM

Quintet Private Bank (Europe)'s DXCM Position: Q2 2026 in Review

Quintet Private Bank (Europe) reduced its DexCom (DXCM) stake by 8.3% in Q2 2026, selling an estimated $20K and leaving 3,300 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #105.

Quintet Private Bank (Europe) first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $306K in Q2 2025. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Quintet Private Bank (Europe) held 3,300 shares of DexCom worth $222K as of Q2 2026.
  • Quintet Private Bank (Europe) sold 300 DexCom shares in Q2 2026, an estimated $20K.
  • DexCom made up 0.01% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #105 holding.
  • Quintet Private Bank (Europe) first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • Quintet Private Bank (Europe)'s DexCom position peaked at $306K in Q2 2025.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.